Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3682812011 | Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 1 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3682814012 | Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
2464572014 | Rosiglitazone+metformin 1mg/500mg tablet (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
2470935018 | Rosiglitazone+metformin 1mg/500mg tablet | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
2477366015 | Rosiglitazone 1mg / metformin 500mg tablet | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
3471164019 | Product containing rosiglitazone 1 mg and metformin 500 mg/1 each oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3486680015 | Product containing rosiglitazone 1 mg and metformin 500 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3501883012 | Rosiglitazone 1 mg and metformin 500 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3569834016 | Product containing only rosiglitazone 1 mg and metformin 500 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3569835015 | Product containing only rosiglitazone 1 mg and metformin 500 mg/1 each oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3682812011 | Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 1 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3682813018 | Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3682814012 | Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Metformin- and rosiglitazone-containing product | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Rosiglitazone (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Metformin (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet (dose form) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Metformin hydrochloride | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Rosiglitazone maleate (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Metformin-containing product in oral dose form | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Rosiglitazone maleate (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Rosiglitazone (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit (attribute) | mg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Metformin hydrochloride | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Metformin hydrochloride | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 500 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit (attribute) | mg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Metformin hydrochloride | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 500 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Rosiglitazone (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Metformin hydrochloride | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing metformin and rosiglitazone in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Rosiglitazone maleate (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | deux | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Metformin and rosiglitazone only product in oral dose form | true | Inferred relationship | Existential restriction modifier (core metadata concept) |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets